Neogen Announces Board Changes Following Director Resignation
Neogen Corp.: Thierry Bernard Resigned From the Board >NEOG
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Raises Target Price to $13
Neogen's Evolving Business Model Keeps Internal Controls a Key Financial Risk
Guggenheim Maintains Neogen(NEOG.US) With Buy Rating, Maintains Target Price $12
Analysts Offer Insights on Healthcare Companies: Danaher (DHR) and Neogen (NEOG)
Neogen | 10-K: Annual report
Neogen Chemicals Sets Record Date for Final Dividend and AGM Voting
Neogen Chemicals Publishes AGM Notice and FY26 Annual Report for Shareholders
Neogen Shares Are Trading Higher After the Company Reported Better-than-expected Q4 Financial Results.
Analysts Conflicted on These Healthcare Names: Neogen (NEOG), Pfizer (PFE) and Hinge Health, Inc. Class A (HNGE)
Here Are the Major Earnings After the Close Thursday
Neogen Fiscal Q4 Adjusted Earnings Rise, Revenue Declines
Earnings Preview: Neogen to Report Financial Results on July 30
$Neogen(NEOG.US)$ is scheduled to release its financial results on July 30 ET. Earnings PreviewAnalysts estimate $Neogen(NEOG.US)$ to post revenue of USD212.35M for 2026Q4, down 5.81% YoY; EPS is
Neogen | 8-K: Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
Express News | Neogen Q4 Adjusted EPS USD 0.09 Vs. IBES Estimate USD -0.07
Express News | Neogen Outlook FY Adjusted Ebitda USD 180-182 Million Vs. IBES Estimate USD 179.9 Million
Express News | Neogen Outlook FY Revenue USD 880-885 Million Vs. IBES Estimate USD 849.6 Million
Express News | Neogen Q4 EPS USD -0.05
Express News | Neogen Q4 Revenue USD 225.3 Million Vs. IBES Estimate USD 212.4 Million